Feedback / Questions
elraglusib (9-ING-41) - Actuate Therap
https://www.globenewswire.com/news-release/2025/12/15/3205465/0/en/Actuate-Therapeutics-Announces-Publication-of-Positive-Phase-II-Clinical-Data-for-Elraglusib-Combined-with-Platinum-Chemotherapy-and-Sequential-Immunotherapy-in-Recurrent-Metastati.html
Dec 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next